Structural basis of peptidomimetic agonism revealed by small-molecule GLP-1R agonists Boc5 and WB4-24

Glucagon-like peptide-1 receptor (GLP-1R) agonists are effective in treating type 2 diabetes and obesity with proven cardiovascular benefits. However, most of these agonists are peptides and require subcutaneous injection except for orally available semaglutide. Boc5 was identified as the first orth...

Descripción completa

Detalles Bibliográficos
Autores principales: Cong, Zhaotong, Zhou, Qingtong, Li, Yang, Chen, Li-Nan, Zhang, Zi-Chen, Liang, Anyi, Liu, Qing, Wu, Xiaoyan, Dai, Antao, Xia, Tian, Wu, Wei, Zhang, Yan, Yang, Dehua, Wang, Ming-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2022
Materias:
Biological Sciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171782/
https://www.ncbi.nlm.nih.gov/pubmed/35561211
http://dx.doi.org/10.1073/pnas.2200155119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171782/
https://www.ncbi.nlm.nih.gov/pubmed/35561211
http://dx.doi.org/10.1073/pnas.2200155119

Ejemplares similares